Subcutaneous shots vs. IV drips: why Chinese patients prefer self‑injection
Remember when all antibody drugs required an hour‑long IV drip in a hospital? Not anymore. Subcutaneous injections (think: an EpiPen for cancer) are taking over. The China antibodies market forecast shows that subcutaneous administration is growing at nearly 15% annually, because it’s convenient, cheaper, and reduces hospital burden. Patients can now take their Herceptin or...
0 Comentários 0 Compartilhamentos 30 Visualizações 0 Anterior